SCHEMBL4622767

SCHEMBL4622767

O=C(O)N1CCC(O)(c2ccc(Cl)cc2)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
CCR1 P32246 5/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
CA14 Q9ULX7 1/20 0.51
CCR3 P51677 1/20 0.50
DRD2 P14416 4/20 0.49
DRD4 P21917 2/20 0.49
DRD3 P35462 2/20 0.49
KDM4E B2RXH2 1/20 0.49
OPRM1 P35372 2/20 0.49
OPRD1 P41143 1/20 0.49
OPRK1 P41145 1/20 0.49
OPRL1 P41146 1/20 0.49
ADRA1A P35348 2/20 0.47
TET3 O43151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2229509 0.90 MEN1 (0.62) KMT2AMEN1CCR1CA12CA1
SCHEMBL1581499 0.86 MEN1 (0.58) KMT2AMEN1CCR1CA12CA1
SCHEMBL23706089 0.85 ALDH1A1 (0.50) KMT2AMEN1CA12CA1CA2
SCHEMBL23365138 0.84 MEN1 (0.60) KMT2AMEN1CCR1CA12CA1
SCHEMBL3541960 0.84 DRD2 (0.49) CCR1DRD2DRD4DRD3OPRM1
SCHEMBL3633446 0.84 CA12 (0.51) KMT2AMEN1CCR1CA12CA1
SCHEMBL3125858 0.84 DRD2 (0.41) KMT2AMEN1CCR1CA12CA1
SCHEMBL1824469 0.83 DRD2 (0.46) KMT2AMEN1CCR1DRD2DRD4
SCHEMBL2535215 0.83 CCR1 (0.46) KMT2AMEN1CCR1DRD2DRD4
SCHEMBL349076 0.82 HSD11B1 (0.61) HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904451-A1 ARYL-ALKYLAMINES AND HETEROARYL-ALKYLAMINES AS PROTEIN KINASE INHIBITORS Astex Therapeutics Limited (GB) 2008-04-02 EP disclosed
WO-2006136830-A1 ARYL-ALKYLAMINES AND HETEROARYL-ALKYLAMINES AS PROTEIN KINASE INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed